scholarly journals Role of p53, PUMA, and Bax in wogonin-induced apoptosis in human cancer cells

2008 ◽  
Vol 75 (10) ◽  
pp. 2020-2033 ◽  
Author(s):  
Dae-Hee Lee ◽  
Clifford Kim ◽  
Lin Zhang ◽  
Yong J. Lee
Keyword(s):  
Cancer Cells ◽  
Human Cancer ◽  
Human Cancer Cells ◽  
Induced Apoptosis

The Role of Sensing Peptides in the Cross-talk between Microbiota and Human Cancer Cells

2018 ◽  
Vol 18 (18) ◽  
pp. 1567-1571
Author(s):  
Anna Lucia Tornesello ◽  
Luigi Buonaguro ◽  
Maria Lina Tornesello ◽  
Franco M. Buonaguro
Keyword(s):  
Cancer Cells ◽  
Cross Talk ◽  
Human Cancer ◽  
Human Cancer Cells ◽  
The Cross

p53 acetylation enhances Taxol-induced apoptosis in human cancer cells

APOPTOSIS ◽  
2012 ◽  
Vol 18 (1) ◽  
pp. 110-120 ◽  
Author(s):  
Jae Hyeong Kim ◽  
Eun-Kyung Yoon ◽  
Hye-Jin Chung ◽  
Seong-Yeol Park ◽  
Kyeong-Man Hong ◽  
...  
Keyword(s):  
Cancer Cells ◽  
Human Cancer ◽  
Human Cancer Cells ◽  
Induced Apoptosis

scholarly journals In-Situ Description of the Role of PtdIns(3,4,5)P3 and PtdSer on PDK1 Regulation in Human Cancer Cells by Advanced Quantitative Microscopy

2014 ◽  
Vol 106 (2) ◽  
pp. 522a-523a
Author(s):  
Gloria de las Heras ◽  
Veronique Calleja ◽  
Banafshe Larijani ◽  
Jose Requejo-Isidro
Keyword(s):  
Cancer Cells ◽  
Human Cancer ◽  
Quantitative Microscopy ◽  
Human Cancer Cells

scholarly journals RuvBL1 Maintains Resistance to TRAIL-Induced Apoptosis by Suppressing c-Jun/AP-1 Activity in Non-Small Cell Lung Cancer

2021 ◽  
Vol 11 ◽  
Author(s):  
Hao Li ◽  
Taoran Zhou ◽  
Yue Zhang ◽  
Hengyi Jiang ◽  
Jing Zhang ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Cancer Cells ◽  
Therapeutic Strategy ◽  
Molecular Mechanisms ◽  
Human Cancer ◽  
Human Cancer Cells ◽  
The Common ◽  
Trail Resistance ◽  
Induced Apoptosis ◽  
Necrosis Factor

Lung cancer is the common malignant tumor with the highest death rate in the world. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) as a potential anticancer agent induces selective apoptotic death of human cancer cells. Unfortunately, approximately half of lung cancer cell lines are intrinsically resistant to TRAIL-induced cell death. In this study, we identified RuvBL1 as a repressor of c-Jun/AP-1 activity, contributing to TRAIL resistance in lung cancer cells. Knocking down RuvBL1 effectively sensitized resistant cells to TRAIL, and overexpression of RuvBL1 inhibited TRAIL-induced apoptosis. Moreover, there was a negative correlation expression between RuvBL1 and c-Jun in lung adenocarcinoma by Oncomine analyses. High expression of RuvBL1 inversely with low c-Jun in lung cancer was associated with a poor overall prognosis. Taken together, our studies broaden the molecular mechanisms of TRAIL resistance and suggest the application of silencing RuvBL1 synergized with TRAIL to be a novel therapeutic strategy in lung cancer treatment.

Sign in / Sign up

Export Citation Format

Share Document